Changliang Ren

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Aromatic Interaction-Driven Adaptive Transformation of Macrocyclic Unimolecular Chloride Channels Into Nanopores.

Aromatic Interaction-Driven Adaptive Transformation of Macrocyclic Unimolecular Chloride Channels Into Nanopores.

Journal: Angewandte Chemie (International ed. in English)

Published: May 18, 2026

Proton-Activated Artificial Channels for pH-Selective Cancer Therapy.

Proton-Activated Artificial Channels for pH-Selective Cancer Therapy.

Journal: Angewandte Chemie (International ed. in English)

Published: November 18, 2025

A trojan horse selenium-containing polymer for protective co-delivery of Fe(II) and cisplatin to boost chemo-ferroptosis synergy via GSH-triggered ROS storm.

A trojan horse selenium-containing polymer for protective co-delivery of Fe(II) and cisplatin to boost chemo-ferroptosis synergy via GSH-triggered ROS storm.

Journal: Materials today. Bio

Published: September 09, 2025

Smart Adaptive Artificial Channels Triggered by Hypoxia for Highly Selective Apoptosis in Cancer Cells.

Smart Adaptive Artificial Channels Triggered by Hypoxia for Highly Selective Apoptosis in Cancer Cells.

Journal: Angewandte Chemie (International ed. in English)

Published: July 09, 2025

Artificial Tyroserleutide Transporters for Synergistic Cancer Therapy.

Artificial Tyroserleutide Transporters for Synergistic Cancer Therapy.

Journal: JACS Au

Published: February 20, 2025

Engineered Reactive Oxygen Species (ROS)-Responsive Artificial H+/Cl- Ion Channels for Targeted Cancer Treatment.

Engineered Reactive Oxygen Species (ROS)-Responsive Artificial H+/Cl- Ion Channels for Targeted Cancer Treatment.

Journal: Angewandte Chemie (International ed. in English)

Published: October 13, 2024

Artificial Ion Transporters as Potent Therapeutics for Channelopathies.

Artificial Ion Transporters as Potent Therapeutics for Channelopathies.

Journal: ChemMedChem

Published: October 12, 2024

Highly Selective Artificial K+ Transporters Reverse Liver Fibrosis In Vivo.

Highly Selective Artificial K+ Transporters Reverse Liver Fibrosis In Vivo.

Journal: JACS Au

Published: June 20, 2024

Combined activation of artificial and natural ion channels for disrupting mitochondrial ion homeostasis towards effective postoperative tumor recurrence and metastasis suppression.

Combined activation of artificial and natural ion channels for disrupting mitochondrial ion homeostasis towards effective postoperative tumor recurrence and metastasis suppression.

Journal: Theranostics

Published: January 30, 2024

Concentration-Driven Evolution of Adaptive Artificial Ion Channels or Nanopores with Specific Anticancer Activities.

Concentration-Driven Evolution of Adaptive Artificial Ion Channels or Nanopores with Specific Anticancer Activities.

Journal: Angewandte Chemie (International ed. in English)

Published: December 07, 2023

Non-Covalently Stapled H+ /Cl- Ion Channels Activatable by Visible Light for Targeted Anticancer Therapy.

Non-Covalently Stapled H+ /Cl- Ion Channels Activatable by Visible Light for Targeted Anticancer Therapy.

Journal: Angewandte Chemie (International ed. in English)

Published: September 29, 2023

Mitochondrial Artificial K+ Channel Construction Using MPTPP@5F8 Nanoparticles for Overcoming Cancer Drug Resistance via Disrupting Cellular Ion Homeostasis.

Mitochondrial Artificial K+ Channel Construction Using MPTPP@5F8 Nanoparticles for Overcoming Cancer Drug Resistance via Disrupting Cellular Ion Homeostasis.

Journal: Advanced healthcare materials

Published: June 26, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026